UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for the first line management of classical Hodgkin lymphoma

British journal of haematology, 2014-07, Vol.166 (1), p.34-49

2014

Volltextzugriff (PDF)

Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young

British journal of haematology, 2001-09, Vol.114 (4), p.878-880

2001

Volltextzugriff (PDF)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Blood advances, 2020-01, Vol.4 (1), p.203-206

2020

Volltextzugriff (PDF)

Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

British journal of haematology, 2022-06, Vol.197 (5), p.558-572

2022

Volltextzugriff (PDF)

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

British journal of haematology, 2020-08, Vol.190 (3), p.394-404

2020

Volltextzugriff (PDF)

A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura

Haematologica (Roma), 2008-01, Vol.93 (1), p.151-152

2008

Volltextzugriff (PDF)

Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

British journal of haematology, 2015-08, Vol.170 (4), p.487-495

2015

Volltextzugriff (PDF)

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma

Blood, 2008-06, Vol.111 (11), p.5359-5370

2008

Volltextzugriff (PDF)

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

Blood, 2004-03, Vol.103 (5), p.1755-1762

2004

Volltextzugriff (PDF)

Combined linkage and association analysis of classical Hodgkin lymphoma

Oncotarget, 2018-04, Vol.9 (29), p.20377-20385

2018

Volltextzugriff (PDF)

A retrospective study of autologous stem cell mobilization to guide an immediate salvage protocol using plerixafor for patients who mobilize stem cells poorly

Journal of clinical apheresis, 2013-10, Vol.28 (5), p.378-380

2013

Volltextzugriff (PDF)

Being underweight may reduce your ability to mobilise peripheral blood stem cells

Transfusion and apheresis science, 2010-12, Vol.43 (3), p.365-367

2010

Volltextzugriff (PDF)

The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma

Experimental hematology, 2007-04, Vol.35 (4), p.596-604

2007

Volltextzugriff (PDF)

Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms

Cancer genetics, 2012-11, Vol.205 (11), p.599-602

2012

Volltextzugriff (PDF)

CD4+ T‐cell responses to Epstein–Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV‐associated non‐Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

British journal of haematology, 2007-10, Vol.139 (1), p.81-89

2007

Volltextzugriff (PDF)

Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma

British journal of haematology, 2002-11, Vol.119 (2), p.475-483

2002

Volltextzugriff (PDF)

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

BLOOD, 2022-11, Vol.140 (Supplement 1), p.9802-9803

2022

Volltextzugriff (PDF)

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

BLOOD, 2021-11, Vol.138 (Supplement 1), p.4671-4671

2021

Volltextzugriff (PDF)

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

Blood, 2022-11, Vol.140 (Supplement 1), p.1761-1764

2022

Volltextzugriff (PDF)

No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study

Blood, 2018-11, Vol.132 (Supplement 1), p.783-783

2018

Volltextzugriff (PDF)

Results of a Phase 2 Trial of the Monocyte-Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) in Chronic Myelomonocytic Leukemia (CMML) — the UK Monocle Study

Blood, 2018-11, Vol.132 (Supplement 1), p.1818-1818

2018

Volltextzugriff (PDF)

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma; The Tier Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.2879-2879

2019

Volltextzugriff (PDF)

Exome Sequencing and Linkage Analysis Implicates Two Candidate Genes On Chromosome 3p in Familial Hodgkin Lymphoma

Blood, 2012-11, Vol.120 (21), p.53-53

2012

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(49)
Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Hematology
(45)
Female
(28)
Middle Aged
(25)
Biological And Medical Sciences
(22)
Male
(22)
Medical Sciences
(22)
Aged
(21)
Adult
(20)
Hematologic And Hematopoietic Diseases
(18)
Medicin Och Hälsovetenskap
(16)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Oncology
(11)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Chemotherapy
(9)
Myelodysplastic Syndromes - Therapy
(9)
Adolescent
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the first line management of classical Hodgkin lymphoma

Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura

Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

Combined linkage and association analysis of classical Hodgkin lymphoma

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study

A retrospective study of autologous stem cell mobilization to guide an immediate salvage protocol using plerixafor for patients who mobilize stem cells poorly

Being underweight may reduce your ability to mobilise peripheral blood stem cells

The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma

Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms

CD4+ T‐cell responses to Epstein–Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV‐associated non‐Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study

Results of a Phase 2 Trial of the Monocyte-Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) in Chronic Myelomonocytic Leukemia (CMML) — the UK Monocle Study

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma; The Tier Trial

Exome Sequencing and Linkage Analysis Implicates Two Candidate Genes On Chromosome 3p in Familial Hodgkin Lymphoma

Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival

Suchergebnisse filtern